Skip to content
★ Sign in to follow
Suzhou Nanomicro Technology Co., Ltd. logo

Suzhou Nanomicro Technology Co., Ltd. Stock: price and insider trades · China

纳微科技

CN·Mcap CN¥15.4BHealth Care

No insider purchase over the last 90 days. The latest, by 牟一萍, was filed 12 May 2023.

Suzhou Nanomicro Technology Co., Ltd.: what insiders have been doing

This page follows insider dealings at Suzhou Nanomicro Technology Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. No insider at Suzhou Nanomicro Technology Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 24 December 2024.

Since 2022, the database holds 16 purchases and 6 sales by insiders of the company.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
22
Thresholds
n/a
Buy Volume
€428,458
16 ops. · all time
Sell Volume
€20M
6 ops. · all time

Who traded when

BuySale
深圳市纳微科技有限公司2 sales

Since the insiders bought

  • Filed 12 May 2023 · 1278 days ago · €16k
    -49.8%
    Entry CN¥42.97 · Close at T+365 CN¥21.59
  • Filed 11 May 2023 · 1279 days ago · €1,139
    -48.6%
    Entry CN¥42.00 · Close at T+365 CN¥21.59
  • Filed 11 May 2023 · 1279 days ago · €18k
    -48.6%
    Entry CN¥42.00 · Close at T+365 CN¥21.59

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,515 of 26,911 companies
53.3
score / 100
Value
26
Quality
80
FCF yld0.5%
Earn yld0.9%
EV/EBITDA59.2x
ROE10%
Gross mgn71%
Net mgn15%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥38.10
Analyst consensus
·
Income statement
RevenueCN¥924.7M
Gross profitCN¥659.4M71% margin
EBITDACN¥260.2M28% margin
Net incomeCN¥136M19.4% margin
Valuation
PER (trailing)73.3x
P/Book7.4x
Beta0.82
Balance sheet & cash
Market capCN¥15.4B
Total debtCN¥32.8M
Free Cash FlowCN¥82.7M
Debt / Equity1%
Profitability & ownership
ROE10.3%
ROA6.3%
% insiders51.5%
% institutions5.2%
Last declaration on 24 December 2024
Declarations22 total
  • ▼
    Related company / holdingExecutives
    42M CNY26SSE
    2,566,000 shares38.6% of flowA股XSHGSSE:173000008373140800
  • ▼
    Related company / holdingExecutives
    74M CNY28SSE
    4,124,000 shares61.4% of flowA股XSHGSSE:173000008356805500
  • ▼
    核心技术人员Executives
    387,360 CNY10SSE
    9,000 shares100.0% of flowA股XSHGSSE:173000006662947200
  • ▲
    董事,高级管理人员Executives
    118,384 CNY26SSE
    2,800 shares10.1% of flowA股XSHGSSE:173000006588467230
    Canonical exit: 10 Aug 2023 (T+90)
  • ▲
    高级管理人员,核心技术人员Executives
    8,648 CNY30SSE
    210 shares9.4% of flowA股XSHGSSE:173000006585622340
    Canonical exit: 9 Aug 2023 (T+90)
  • ▲
    董事,高级管理人员Executives
    209,000 CNY27SSE
    5,000 shares17.8% of flowA股XSHGSSE:173000006585594000
    Canonical exit: 9 Aug 2023 (T+90)
  • ▲
    董事Executives
    139,356 CNY28SSE
    3,300 shares26.1% of flowA股XSHGSSE:173000006585593950
    Canonical exit: 9 Aug 2023 (T+90)
  • ▲
    高级管理人员Executives
    8,480 CNY29SSE
    200 shares3.9% of flowA股XSHGSSE:173000006585594020
    Canonical exit: 9 Aug 2023 (T+90)
  • ▲
    高级管理人员,核心技术人员Executives
    83,860 CNY37SSE
    2,000 shares90.6% of flowA股XSHGSSE:173000006579380770
    Canonical exit: 7 Aug 2023 (T+90)
  • ▲
    高级管理人员Executives
    69,789 CNY37SSE
    1,666 shares100.0% of flowA股XSHGSSE:173000006579222370
    Canonical exit: 7 Aug 2023 (T+90)
  • ▲
    高级管理人员Executives
    209,150 CNY37SSE
    5,000 shares96.1% of flowA股XSHGSSE:173000006579222500
    Canonical exit: 7 Aug 2023 (T+90)
  • ▲
    董事,高级管理人员Executives
    837,600 CNY32SSE
    20,000 shares71.4% of flowA股XSHGSSE:173000006579222430
    Canonical exit: 7 Aug 2023 (T+90)
  • ▲
    监事Executives
    500,400 CNY33SSE
    12,000 shares100.0% of flowA股XSHGSSE:173000006579222340
    Canonical exit: 7 Aug 2023 (T+90)
  • ▲
    高级管理人员Executives
    501,994 CNY37SSE
    11,674 shares100.0% of flowA股XSHGSSE:173000006575416500
    Canonical exit: 6 Aug 2023 (T+90)
  • ▲
    董事Executives
    60,415 CNY26SSE
    1,405 shares11.3% of flowA股XSHGSSE:173000006575416540
    Canonical exit: 6 Aug 2023 (T+90)
  • ▲
    董事Executives
    42,400 CNY25SSE
    1,000 shares25.2% of flowA股XSHGSSE:173000006545939040
    Canonical exit: 27 Jul 2023 (T+90)
  • ▲
    董事Executives
    125,688 CNY29SSE
    3,000 shares74.8% of flowA股XSHGSSE:173000006545939000
    Canonical exit: 26 Jul 2023 (T+90)
  • ▲
    董事Executives
    8,352 CNY22SSE
    200 shares0.7% of flowA股XSHGSSE:173000006535227040
    Canonical exit: 26 Jul 2023 (T+90)
  • ▲
    董事Executives
    336,104 CNY28SSE
    8,000 shares62.6% of flowA股XSHGSSE:173000006545939100
    Canonical exit: 26 Jul 2023 (T+90)
  • ▼
    董事Executives
    6M CNY9SSE
    105,750 shares24.9% of flowA股XSHGSSE:173000006267298880
  • ▼
    董事Executives
    11M CNY11SSE
    177,428 shares42.7% of flowA股XSHGSSE:173000006180894560
  • ▼
    董事Executives
    8M CNY10SSE
    99,863 shares32.4% of flowA股XSHGSSE:173000006180894600

22 of 22 declarations

About Suzhou Nanomicro Technology Co., Ltd.

纳微科技 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It specializes in the development of innovative technologies and products for the medical field.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations